Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure

被引：0
|
作者：
Mari Katsumata
Nobuhito Hirawa
Koichiro Sumida
Minako Kagimoto
Yosuke Ehara
Yuki Okuyama
Megumi Fujita
Akira Fujiwara
Mayumi Kobayashi
Yusuke Kobayashi
Yuichiro Yamamoto
Sanae Saka
Keisuke Yatsu
Tetsuya Fujikawa
Yoshiyuki Toya
Gen Yasuda
Kouichi Tamura
Satoshi Umemura
机构：
[1] Yokohama City University Medical Center,Department of Nephrology and Hypertension
[2] Yokohama City University School of Medicine,Department of Medical Science and Cardiorenal Medicine
[3] Yokosuka City Hospital,Department of Nephrology
[4] Yokohama National University,Center for Health Service Sciences
[5] Yokohama Rosai Hospital,undefined
来源：
Clinical and Experimental Nephrology | 2017年 / 21卷
关键词：
Chronic kidney disease; Tolvaptan; Urine osmolality; Hyponatremia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：858 / 865
页数：7
相关论文
共 50 条
  • [1] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Katsumata, Mari
    Hirawa, Nobuhito
    Sumida, Koichiro
    Kagimoto, Minako
    Ehara, Yosuke
    Okuyama, Yuki
    Fujita, Megumi
    Fujiwara, Akira
    Kobayashi, Mayumi
    Kobayashi, Yusuke
    Yamamoto, Yuichiro
    Saka, Sanae
    Yatsu, Keisuke
    Fujikawa, Tetsuya
    Toya, Yoshiyuki
    Yasuda, Gen
    Tamura, Kouichi
    Umemura, Satoshi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 858 - 865
  • [2] The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
    Tomoyuki Otsuka
    Yukinao Sakai
    Dai Ohno
    Tsuneo Murasawa
    Naoki Sato
    Shuichi Tsuruoka
    [J]. Clinical and Experimental Nephrology, 2013, 17 : 834 - 838
  • [3] The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
    Otsuka, Tomoyuki
    Sakai, Yukinao
    Ohno, Dai
    Murasawa, Tsuneo
    Sato, Naoki
    Tsuruoka, Shuichi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (06) : 834 - 838
  • [4] Effects of Oral Tolvaptan Administration in Patients Hospitalized for Chronic Heart Failure with Preserved Ejection Fraction and Chronic Kidney Disease
    Shiraishi, Kozo
    Ikeda, Yasuhiro
    Miyazaki, Yosuke
    Okamura, Takayuki
    Miura, Toshiro
    Matsuzaki, Masunori
    [J]. JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S152 - S152
  • [5] Effect of Tolvaptan in Patients With Chronic Kidney Disease Due to Diabetic Nephropathy With Heart Failure
    Sato, Eiichi
    Nakamura, Tsukasa
    Amaha, Mayuko
    Nomura, Mayumi
    Matsumura, Daisuke
    Yamagishi, Hidetsugu
    Ono, Yuko
    Ueda, Yoshihiko
    [J]. INTERNATIONAL HEART JOURNAL, 2014, 55 (06) : 533 - 538
  • [6] Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease
    Uemura, Yusuke
    Shibata, Rei
    Takemoto, Kenji
    Uchikawa, Tomohiro
    Koyasu, Masayoshi
    Ishikawa, Shinji
    Mitsuda, Takayuki
    Miura, Ayako
    Imai, Ryo
    Iwamiya, Satoshi
    Ozaki, Yuta
    Kato, Tomohiro
    Miura, Takanori
    Watarai, Masato
    Murohara, Toyoaki
    [J]. HEART AND VESSELS, 2016, 31 (10) : 1643 - 1649
  • [7] Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease
    Yusuke Uemura
    Rei Shibata
    Kenji Takemoto
    Tomohiro Uchikawa
    Masayoshi Koyasu
    Shinji Ishikawa
    Takayuki Mitsuda
    Ayako Miura
    Ryo Imai
    Satoshi Iwamiya
    Yuta Ozaki
    Tomohiro Kato
    Takanori Miura
    Masato Watarai
    Toyoaki Murohara
    [J]. Heart and Vessels, 2016, 31 : 1643 - 1649
  • [8] Tolvaptan is useful and safe for the treatment of very elderly patients with heart failure and chronic kidney disease
    Yoshioka, K. Kei
    Yoshio, T.
    Matsumura, K.
    Noda, T.
    Ueyama, T.
    Sakuma, T.
    Park, H.
    Iharada, Y.
    Yamamoto, Y.
    Shiojima, I.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 45 - 45
  • [9] Tolvaptan for heart failure in chronic kidney disease patients: a systematic review and meta-analysis
    Sen, J. Jonathan
    Chung, E.
    Mcgill, D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 235 - 235
  • [10] Impact of early tolvaptan treatment for very elderly patients with heart failure and chronic kidney disease
    Yoshioka, K. Kei
    Yokoi, M.
    Otagaki, M.
    Yoshio, T.
    Matsumura, K.
    Noda, T.
    Sakuma, T.
    Ueyama, T.
    Iharada, Y.
    Park, H.
    Yamamoto, Y.
    Shiojima, I.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 230 - 230
12345